Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes

Hussaini Syed Sha Qhattal; Tanvirul Hye; Amer Alali; Xinli Liu

doi:10.1021/nn405839n

journal article May 15, 2014

Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes

Hussaini Syed Sha Qhattal Tanvirul Hye Amer Alali Xinli Liu

ACS Nano Vol. 8 No. 6 pp. 5423-5440 · American Chemical Society (ACS)

View at Publisher Save 10.1021/nn405839n

Topics

No keywords indexed for this article. Browse by subject →

References

90

[1]

Schroeder A. Nat. Rev. Cancer (2012) 10.1038/nrc3180

[2]

Liposomal drug delivery systems: From concept to clinical applications

Pieter R. Cullis

Advanced Drug Delivery Reviews 2013 10.1016/j.addr.2012.09.037

[3]

Allen T. M. Science (2004) 10.1126/science.1095833

[4]

Papahadjopoulos D. Proc. Natl. Acad. Sci. U.S.A. (1991) 10.1073/pnas.88.24.11460

[5]

Allen T. M. Biochim. Biophys. Acta (1991) 10.1016/0005-2736(91)90246-5

[6]

Klibanov A. L. FEBS Lett. (1990) 10.1016/0014-5793(90)81016-h

[7]

Matsumura Y. Cancer Res. (1986)

[8]

Yuan F. Cancer Res. (1994)

[9]

Maeda H. J. Controlled Release (2000) 10.1016/s0168-3659(99)00248-5

[10]

Fang J. Adv. Drug Delivery Rev. (2011) 10.1016/j.addr.2010.04.009

[11]

Alexis F. Mol. Pharm. (2008) 10.1021/mp800051m

[12]

Nanocarriers as an emerging platform for cancer therapy

Dan Peer, Jeffrey M. Karp, Seungpyo Hong et al.

Nature Nanotechnology 2007 10.1038/nnano.2007.387

[13]

Hatakeyama H. Adv. Drug Delivery Rev. (2011) 10.1016/j.addr.2010.09.001

[14]

Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

Katrin Knop, Richard Hoogenboom, Dagmar Fischer et al.

Angewandte Chemie International Edition 2010 10.1002/anie.200902672

[15]

Mishra S. Eur. J. Cell Biol. (2004) 10.1078/0171-9335-00363

[16]

Hong R. L. Clin. Cancer Res. (1999)

[17]

Li S.-D. Mol. Pharm. (2008) 10.1021/mp800049w

[18]

Chou L. Y. Chem. Soc. Rev. (2011) 10.1039/c0cs00003e

[19]

Kinam P. ACS Nano (2013)

[20]

Huang X. ACS Nano (2010) 10.1021/nn102055s

[21]

Pirollo K. F. Trends Biotechnol. (2008) 10.1016/j.tibtech.2008.06.007

[22]

Kwon I. J. Controlled Release (2012) 10.1016/j.jconrel.2012.07.010

[23]

Bae Y. J. Controlled Release (2011) 10.1016/j.jconrel.2011.06.001

[24]

Perrault S. Nano Lett. (2009) 10.1021/nl900031y

[25]

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

Alexandre Albanese, Peter S. Tang, Wan-Mui Chan

Annual Review of Biomedical Engineering 2012 10.1146/annurev-bioeng-071811-150124

[26]

Ruenraroengsak P. J. Controlled Release (2010) 10.1016/j.jconrel.2009.10.032

[27]

Koo H. Acc. Chem. Res. (2011) 10.1021/ar2000138

[28]

Oh E. J. J. Controlled Release (2010) 10.1016/j.jconrel.2009.09.010

[29]

Prestwich G. D. J. Controlled Release (2011) 10.1016/j.jconrel.2011.04.007

[30]

Zoller M. Nat. Rev. Cancer (2011) 10.1038/nrc3023

[31]

Naor D. Adv. Cancer Res. (1997) 10.1016/s0065-230x(08)60101-3

[32]

Toole B. P. Nat. Rev. Cancer (2004) 10.1038/nrc1391

[33]

Toole B. P. Clin. Cancer Res. (2009) 10.1158/1078-0432.ccr-09-0479

[34]

Misra S. FEBS J. (2011) 10.1111/j.1742-4658.2011.08071.x

[35]

Yerushalmi N. Arch. Biochem. Biophys. (1994) 10.1006/abbi.1994.1387

[36]

Peer D. Int. J. Cancer (2004) 10.1002/ijc.11615

[37]

Eliaz R. E. Cancer Res. (2001)

[38]

Chono S. J. Controlled Release (2008) 10.1016/j.jconrel.2008.07.006

[39]

Peer D. Science (2008) 10.1126/science.1149859

[40]

Esposito G. ChemMedChem (2008) 10.1002/cmdc.200800234

[41]

Platt V. M. Mol. Pharm. (2008) 10.1021/mp800024g

[42]

Akima K. J. Drug Target (1996) 10.3109/10611869609046255

[43]

Auzenne E. Neoplasia (2007) 10.1593/neo.07229

[44]

Banzato A. Clin. Cancer Res. (2008) 10.1158/1078-0432.ccr-07-2019

[45]

Bassi P. F. J. Urol. (2011) 10.1016/j.juro.2010.09.073

[46]

Mittapalli R. K. Mol. Cancer Ther. (2013) 10.1158/1535-7163.mct-13-0132

[47]

Galer C. E. Oral Oncol. (2011) 10.1016/j.oraloncology.2011.07.029

[48]

Coradini D. Clin. Cancer Res. (2004) 10.1158/1078-0432.ccr-04-0349

[49]

Peer D. Neoplasia (2004) 10.1593/neo.03460

[50]

Qhattal H. S. Mol. Pharm. (2011) 10.1021/mp2000428

Showing 50 of 90 references

Metrics

162

Citations

90

References

Details

Published: May 15, 2014
Vol/Issue: 8(6)
Pages: 5423-5440
License: View

Authors

H

Hussaini Syed Sha Qhattal

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States

T

Tanvirul Hye

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States

A

Amer Alali

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States

X

Xinli Liu

Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79106, United States

Cite This Article

Hussaini Syed Sha Qhattal, Tanvirul Hye, Amer Alali, et al. (2014). Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes. ACS Nano, 8(6), 5423-5440. https://doi.org/10.1021/nn405839n

Hyaluronan Polymer Length, Grafting Density, and Surface Poly(ethylene glycol) Coating Influence in Vivo Circulation and Tumor Targeting of Hyaluronan-Grafted Liposomes

You May Also Like